Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2014

Conditions
TransplantationImmunosuppressionDrug Interaction
Interventions
DRUG

Mycophenolate sodium

Daily dose: 720mg, 1080mg, 1440mg. Application alone or together with Pantozol®.

DRUG

Pantoprazole

Daily dose: 40mg. Application together with CellCept® or Myfortic® .

DRUG

Mycophenolate mofetil

Daily dose: 1000mg, 1500mg, 2000mg. Application alone or with Pantozol® .

Trial Locations (1)

10117

Charité Hospital Campus Mitte, Berlin

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

Klemens Budde

OTHER